Menu
Recruiting NCT07594444

Whey Protein and Adaptogenic Supplementation in Physically Active Females

No phase Interventional Sports Nutritional Sciences Recovery Muscle Strength Recovery Muscle Strength

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Whey protein, Whey Protein With Adaptogenic Blend, Plant Protein Supplement, Plant Protein With Adaptogenic Blend.
Who it may be relevant to
Registry conditions: Sports Nutritional Sciences, Recovery, Muscle Strength Recovery, Muscle Strength. Basic parameters: 18 years — 45 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United Kingdom
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Whey Protein and Adaptogenic Herb Supplementation in Physically Active Females: A Randomised Controlled Trial

Overview

The goal of this clinical trial is to learn whether whey protein or plant protein supplements, with or without an adaptogenic herb blend, can improve strength, recovery, stress, and wellbeing in active females. The adaptogenic blend contains ashwagandha root extract and shatavari root extract. The main questions the study aims to answer are: * Do whey protein and plant protein supplements improve muscle strength and recovery in physically active females? * Does adding ashwagandha and shatavari improve stress, recovery, sleep, and wellbeing compared with protein alone? * Are there differences between whey protein and plant protein when combined with the adaptogenic blend? Researchers will compare four supplement groups: * Whey protein * Whey protein with ashwagandha and shatavari * Plant protein * Plant protein with ashwagandha and shatavari Participants will: * Take their assigned supplement daily for 6 weeks * Attend testing sessions before and after the intervention * Complete questionnaires about recovery, sleep, stress, soreness, and digestive health * Provide saliva samples to measure stress, hormone, immune, and inflammation markers * Complete muscle strength tests, including handgrip strength and push-up testing * Complete a 24-hour dietary recall. The study includes physically active females aged 18 to 45 years who regularly participate in structured training.

Interventions

  • Dietary supplement Whey protein
    Participants will consume a whey protein supplement daily for 6 weeks. The supplement will be provided in identical blank tubs. Participants will be instructed to maintain their usual diet and training habits throughout the intervention period.
  • Dietary supplement Whey Protein With Adaptogenic Blend
    Participants will consume a whey protein supplement containing ashwagandha KSM-66® root extract (250 mg) and shatavari SRI-81™ root extract (300 mg) daily for 6 weeks. Supplements will be provided in identical blank tubs. Participants will maintain usual diet and training habits during the study.
  • Dietary supplement Plant Protein Supplement
    Participants will consume a plant-based protein supplement daily for 6 weeks. The supplement will be provided in identical blank tubs. Participants will be instructed to maintain their usual diet and training habits throughout the intervention period.
  • Dietary supplement Plant Protein With Adaptogenic Blend
    Participants will consume a plant-based protein supplement containing ashwagandha KSM-66® root extract (250 mg) and shatavari SRI-81™ root extract (300 mg) daily for 6 weeks. Supplements will be provided in identical blank tubs. Participants will maintain usual diet and training habits during the study.

Primary outcome measures

  • Salivary Cortisol Concentration [Time frame: Baseline and Week 6]
Secondary outcome measures (9)
  • Handgrip Strength [Time frame: Baseline and Week 6]
  • Upper Body Muscular Endurance [Time frame: Baseline and Week 6]
  • Perceived Recovery and Wellbeing [Time frame: Baseline and Week 6]
  • Salivary DHEA-S Concentration [Time frame: Baseline and Week 6]
  • Perceived Gastrointestinal Health [Time frame: Baseline and Week 6]
  • Dietary Intake [Time frame: Baseline and Week 6]
  • Salivary Oestradiol Concentration [Time frame: Baseline and Week 6]
  • Salivary Secretory Immunoglobulin A (sIgA) Concentration [Time frame: Baseline and Week 6]
  • Salivary C-reactive Protein Concentration [Time frame: Baseline to Week 6]

Eligibility criteria

Inclusion criteria

  • Female, aged 18-45 years
  • Currently participating in regular structured athletic or physical training (≥3 sessions per week)
  • Free from musculoskeletal injury that would prevent testing
  • Willing to maintain usual diet and training habits during the study
  • Not currently using protein supplements or adaptogenic supplements

Exclusion criteria

  • Pregnant, breastfeeding, or planning pregnancy during the study period
  • Known allergy or sensitivity to dairy, pea protein, pumpkin seed, chia seed, ashwagandha, shatavari, or nightshades
  • Current use of prescribed medication that may interact with the supplements
  • Thyroid disorders, autoimmune conditions, hormone-sensitive conditions, or other medical conditions that may be affected by supplementation
  • Diagnosed eating disorder or condition affecting protein metabolism
  • Current musculoskeletal injury preventing participation in testing
  • Current use of other protein supplements or adaptogens

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Double blind
Primary purpose
Basic science

Study locations

United Kingdom · 1 center
  • Strength and Nutrition Ltd — Brighton

Identifiers

NCT: NCT07594444 · ASH-WHEY-001

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗